Impact of IgAN on Quality of Life
HCPLive
NOVEMBER 25, 2024
Panelists discuss how IgA nephropathy affects patients’ quality of life, addressing both the physical symptoms and the emotional challenges associated with the condition.
This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
HCPLive
NOVEMBER 25, 2024
Panelists discuss how IgA nephropathy affects patients’ quality of life, addressing both the physical symptoms and the emotional challenges associated with the condition.
American Heart News - Heart News
JULY 1, 2024
Statement Highlights: Palliative medication management focuses on providing relief from symptoms and enhancing quality of life for people with cardiovascular disease throughout the various stages of the disease. Decisions about initiating, adjusting.
HCPLive
JANUARY 2, 2024
Various factors related to demographics, psychosocial behavior variables, and clinical characteristics were linked to health-related quality of life in patients with gout.
HCPLive
JUNE 24, 2024
A meta-analysis shows hand eczema has a moderate-to-severe impact on quality of life and anxiety.
HCPLive
APRIL 18, 2024
New phase 3 findings show daily oral budesonide reduces eGFR decline while maintaining patient quality of life over 2 years.
HCPLive
OCTOBER 14, 2024
A study found that migraine-related disability worsens health-related quality of life, with gender-specific differences, particularly affecting women with mild disability.
HCPLive
AUGUST 9, 2024
Interim analysis of STELLAR showed health-related quality of life domains were within a normal range after hematopoietic cell transplant for SCD.
HCPLive
SEPTEMBER 21, 2024
Oral vitamin D improves vitamin D status and quality of life in IBS patients but does not significantly reduce symptom severity, a new study suggests.
HCPLive
DECEMBER 11, 2023
In a new study, patients with ADHD on cannabis-based medicinal products had significant improvements for anxiety, sleep quality, and health-related quality of life.
Medical Xpress - Cardiology
DECEMBER 12, 2023
Stem cell-based therapy improved quality of life for patients with advanced heart failure, Mayo Clinic researchers and international collaborators discovered in a late-stage multinational clinical trial.
HCPLive
OCTOBER 31, 2024
Mohammad Abuassi, MD, explains how classifying IBS based on triggers can aid the development of effective, personalized approaches to management.
Medical Xpress - Cardiology
SEPTEMBER 2, 2024
Long-term use of beta-blockers in patients with myocardial infarction and preserved heart function does not significantly change quality of life or well-being compared to no beta-blockers.
HCPLive
FEBRUARY 20, 2024
Patients with fibromyalgia and cognitive dysfunction report feeling a loss of identify and impaired social interaction.
HCPLive
DECEMBER 18, 2024
Panelists discuss how familial chylomicronemia syndrome (FCS) affects patients quality of life, particularly in terms of their emotional well-being, employment burden, and social isolation due to recurrent acute pancreatitis, and explore the significant economic burden it places on patients and their families.
HeartRhythm
SEPTEMBER 20, 2024
Data on long-term effects of catheter ablation versus antiarrhythmic drugs (AAD) on health-related quality of life (HRQoL) and atrial fibrillation (AF) burden are limited.
HCPLive
AUGUST 4, 2024
Responders at week 104 demonstrated more significant changes from baseline and achieved normative values in PROs compared with non-responders.
HCPLive
DECEMBER 9, 2024
A recent study examined the phase 3 trials ADVANCE, PROGRESS, and ELEVATE and saw atogepant 60 mg as a preventive migraine treatment improves quality of life and functioning.
DAIC
JUNE 21, 2024
milla1cf Fri, 06/21/2024 - 20:10 June 21, 2024 — UC San Francisco interventional cardiologists and interventional echocardiographers recently performed the health system’s first commercial transcatheter tricuspid valve replacement procedure using the Edwards EVOQUE system. by the Food and Drug Administration.
HCPLive
OCTOBER 9, 2024
Younossi explains how MASH negatively impacts patients’ quality of life and describes resmetirom’s benefit across multiple HRQoL domains.
HCPLive
AUGUST 12, 2024
Experts on atopic dermatitis describe the burden of the disease and provide clinical insights on counseling patients who are experiencing sleep disturbances.
HCPLive
SEPTEMBER 22, 2024
Obesity and advanced fibrosis were independent predictors of impaired health-related quality of life in people with T2D.
HCPLive
AUGUST 31, 2024
RESHAPE-HF2 shows mitral transcatheter edge-to-edge repair (M-TEER) reduces heart failure hospitalizations and improves quality of life vs optimal medical therapy alone.
American College of Cardiology
OCTOBER 27, 2024
Food and Drug Administration (FDA) this year for tricuspid regurgitation (TR) are safe, effective and improve quality of life (QOL) at one year, according to studies published in JACC and simultaneously being presented at TCT 2024. Two devices approved by the U.S.
HCPLive
AUGUST 8, 2024
In this analysis, investigators highlighted the perceptions of individuals with HS and atopic dermatitis and assessed higher rates of stigmatization.
HCPLive
OCTOBER 8, 2024
New research presented at CHEST 2024 highlights ensifentrine’s effectiveness in improving lung function, symptoms, and quality of life for COPD patients, regardless of disease severity.
HCPLive
SEPTEMBER 24, 2024
Adding semaglutide to standard hidradenitis suppurative therapies achieved improvements in quality of life and fewer disease-related flares.
HCPLive
OCTOBER 16, 2024
Incorporating baked milk products into a regular diet may improve growth and quality of life in milk-allergic children.
HCPLive
OCTOBER 9, 2024
A meta-analysis shows that wet cupping reduces migraine intensity but doesn't improve quality of life. Adjunctive therapies offer limited additional benefits.
HCPLive
JULY 15, 2024
Shawn Kwatra, MD, discusses the effects of poorly controlled or severe atopic dermatitis on patients’ quality of life and how to measure patient-reported outcomes.
HCPLive
JULY 18, 2024
Shawn Kwatra, MD, discusses the durability of treatments for atopic dermatitis and provides advice for clinicians on improving patients’ quality of life.
HCPLive
NOVEMBER 17, 2024
Patients with PBC and moderate/severe pruritus face a greater health-related quality of life burden and impaired activity than those with no/mild itch.
Heart BMJ
JULY 25, 2024
Background We aimed to evaluate the association between atrial fibrillation (AF) burden, duration and number of episodes with healthcare utilisation and quality of life in patients with early paroxysmal AF without a history of AF. Patients were monitored with an insertable cardiac monitor for 1 year.
Science Daily - Heart Disease
APRIL 10, 2024
Over 200 million people around the world experience peripheral artery disease (PAD) -- a condition caused by the narrowing of the blood vessels from the heart to the lower limbs that leads to pain when walking -- and for roughly 1-in-10 this advances to chronic limb-threatening ischemia (CLTI), an advanced form of PAD.
American College of Cardiology
NOVEMBER 16, 2024
In patients with obesity and heart failure with preserved ejection fraction (HFpEF), weekly treatment with tirzepatide over approximately two years reduced the risk of worsening heart failure events, based on findings from the SUMMIT trial.
Medical Xpress - Cardiology
FEBRUARY 15, 2024
While the lifesaving operation improves the quality of life and longevity for most recipients, organ rejection remains a risk, with acute rejection occurring in up to 32% of recipients within the first year. More than 4,500 heart transplants were performed in the U.S.
HCPLive
NOVEMBER 4, 2024
Risankizumab achieves significantly higher rates of skin clearance and improved quality of life versus deucravacitinib in matching-adjusted indirect comparison analysis.
HCPLive
DECEMBER 7, 2024
Notably, participants without platelet responses also experienced improvements in fatigue, which may be due to the monoclonal antibodys anti-inflammatory action.
HCPLive
JUNE 13, 2024
Findings highlight an urgent need for improved gout management strategies to reduce costs, improve quality of life, and reduce gout symptoms in patients with comorbid gout and CKD.
HCPLive
NOVEMBER 11, 2024
Combining interventions yielded no significant differences in outcomes, pain, or quality-of-life.
American Heart News - Stroke News
AUGUST 19, 2024
Statement Highlights: The latest research indicates that 16% to 85% of people recovering from a stroke experience at least one psychosocial symptom, including depression, anxiety, stress, fatigue and/or decreased quality of life. Critical nursing.
HCPLive
NOVEMBER 6, 2024
Teva presents 2 findings at Psych Congress 2024: TEV’749’s effects on social function and quality of life in adults with schizophrenia and risperidone adherence patterns.
DAIC
MAY 16, 2024
milla1cf Thu, 05/16/2024 - 15:35 May 16, 2024 — A recent publication in the American Heart Association Circulation highlights a comprehensive investigation to assess the impact of revascularization strategies on the health-related quality of life (HRQoL) of patients suffering from chronic limb-threatening ischemia.
HCPLive
AUGUST 30, 2024
HELIOS-B trial shows vutrisiran reduces all-cause mortality and CV events in ATTR-CM, with benefits consistent regardless of tafamidis use.
HCPLive
AUGUST 12, 2024
Adjusted analyses reveal a statistically significantly higher prescription medication cost in patients with RA compared to those without.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content